Two biotech companies agreed to a share-swap merger in what they declare is the first move in building Australia’s biggest pure biotech company, with more acquisitions to come.
Two biotech companies agreed to a share-swap merger in what they declare is the first move in building Australia’s biggest pure biotech company, with more acquisitions to come.
